"The use of aspirin, acetyl salicylic acid, to thin out the blood.
Aspirin interferes with normal platelets aggregation, thus reduce clotting (but
it also causes abnormal bleeding). However, according to some the thick blood
is due to too much acid, not the aggregation of platelets. None of the
trials on aspirin show any benefit in preventing heart attack, such as the two
trials reported in the British Medical Journal in 1974 i p 436 and in The
Lancet in 1979 ii p 1313. A big study costing $16,000,000 by the National Heart
Lung and Blood Institute, reported in JAMA (2/15/80), again showed no heart
benefit. Another US trial, called the Physicians’ health Study, used Bufferin.
The results, reported in the New England Journal of Medicine (1/28/88), showed
no improvement for fatal heart attacks or survival rate. However, non-fatal
heart attacks were reduced by 40%, which is most likely due to the
neutralization of acids by the magnesium contained in Bufferin. Better results
will be achieved if magnesium were used alone. " Yee-Wing Tong, M.D.
No comments:
Post a Comment